RxDoctor Payments Data

Tenesha Williams

Psychiatric/Mental Health · Tallahassee, FLNPI 1629745641

Payments from drug & device makers

$3,135in general payments, 2019–2025

Across 178 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$545
  • Teva Pharmaceuticals USA, Inc.$497
  • Johnson & Johnson$379
  • Neurocrine Biosciences, Inc.$329
  • Alkermes, Inc.$314
  • Vanda Pharmaceuticals Inc.$273
  • plus $798 from 10 others

What the payments were for

  • Food & beverage$3,135100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,135 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$9,222
Medicare patients
35
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl49$78,150
Aripiprazole74$5,745
Vilazodone Hcl24$3,056
Lurasidone Hcl32$2,729
Trazodone Hcl144$2,387
Lamotrigine195$2,007
Quetiapine Fumarate166$1,918
Buspirone Hcl132$1,818
Duloxetine Hcl130$1,776
Ramelteon17$1,687
Atomoxetine Hcl12$1,619
Hydroxyzine Hcl88$1,258
Mirtazapine35$1,021
Bupropion XlBupropion Hcl71$923
Olanzapine50$906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$545$78,15049 claims
Almatica Pharma LLCSertraline Hcl$39$62987 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →